SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-138038
Filing Date
2021-11-12
Accepted
2021-11-12 16:06:18
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acxp-20210930x10q.htm   iXBRL 10-Q 1457081
2 EXHIBIT 31.1 acxp-20210930xex31d1.htm EX-31.1 14336
3 EXHIBIT 31.2 acxp-20210930xex31d2.htm EX-31.2 14358
4 EXHIBIT 32.1 acxp-20210930xex32d1.htm EX-32.1 5709
5 EXHIBIT 32.2 acxp-20210930xex32d2.htm EX-32.2 7246
  Complete submission text file 0001104659-21-138038.txt   4345509

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acxp-20210930.xsd EX-101.SCH 37391
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acxp-20210930_cal.xml EX-101.CAL 20239
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acxp-20210930_def.xml EX-101.DEF 132918
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acxp-20210930_lab.xml EX-101.LAB 285119
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acxp-20210930_pre.xml EX-101.PRE 241012
11 EXTRACTED XBRL INSTANCE DOCUMENT acxp-20210930x10q_htm.xml XML 458374
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40536 | Film No.: 211403415
SIC: 2834 Pharmaceutical Preparations